{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:21:00Z","timestamp":1789147260399,"version":"build-2803163510"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Etomidate is a widely utilized anaesthetic agent for the induction of general anesthesia, recognized for its rapid onset and minimal hemodynamic suppression effects. However, its clinical application is constrained by several adverse effects, including adrenal cortex suppression, postoperative nausea and vomiting, and myoclonus. In recent years, there has been a growing global research focus on structural modifications of the etomidate molecule, aiming to simultaneously ameliorate its adverse effects and optimize its hemodynamic stability efficacy. Methoxycarbonyl-etomidate and carboetomidate are inhibited due to the accumulation of their metabolites. CPMM and ET-26HCI have entered the clinical trial stage, but there are still adverse reactions and challenges for the next phase of research. This comprehensive review systematically examines recent scientific advancements in this field, focusing on structural modifications, pharmacological properties, and clinical translation of these novel compounds.<\/jats:p>","DOI":"10.3389\/fphar.2025.1614865","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:26:27Z","timestamp":1760419587000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Recent progress in the development of etomidate analogues"],"prefix":"10.3389","volume":"16","author":[{"given":"Yanting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchen","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/BF01711723","article-title":"Adrenocortical suppression by a single induction dose of etomidate","volume":"62","author":"Allolio","year":"1984","journal-title":"Klin. Wochenschr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/(sici)1098-1128(200001)20:1<58::aid-med3>3.0.co;2-x","article-title":"Soft drug design: general principles and recent applications","volume":"20","author":"Bodor","year":"2000","journal-title":"Med. Res. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1097\/CCM.0b013e31825fec26","article-title":"Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis","volume":"40","author":"Chan","year":"2012","journal-title":"Crit. Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e13995","DOI":"10.7717\/peerj.13995","article-title":"The preclinical pharmacological study of a novel intravenous anesthetic, ET-26 hydrochloride, in aged rats","volume":"10","author":"Chang","year":"2022","journal-title":"PeerJ"},{"key":"B5","first-page":"128","volume-title":"Design, synthesis and preclinical pharmacological study of etomidate analogues","author":"Chaoyi","year":"2021"},{"key":"B6","first-page":"982","article-title":"Effects of etomidate on endocrine system and solutions: advances in etomidate analogues","volume":"31","author":"Chen Shoushou","year":"2016","journal-title":"West China Med. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.4103\/2152-7806.109179","article-title":"Anesthetic drug development: novel drugs and new approaches","volume":"4","author":"Chitilian","year":"2013","journal-title":"Surg. Neurol. Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/ALN.0b013e3181ae63d1","article-title":"Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression","volume":"111","author":"Cotten","year":"2009","journal-title":"Anesthesiology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/ALN.0b013e3181cf40ed","article-title":"Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function","volume":"112","author":"Cotten","year":"2010","journal-title":"Anesthesiology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1213\/01.ane.0000167269.62966.af","article-title":"Different conditions that could result in the bispectral index indicating an incorrect hypnotic state","volume":"101","author":"Dahaba","year":"2005","journal-title":"Anesth. Analg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/s13054-014-0560-7","article-title":"Etomidate for anesthesia induction: friends or foe in major cardiac surgery?","volume":"18","author":"De Jong","year":"2014","journal-title":"Crit. Care"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1210\/jcem-59-6-1143","article-title":"Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation","volume":"59","author":"de Jong","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.13375\/j.cnki.wcjps.2017.04.012","article-title":"Protective effects and mechanism of etomidate on focal cerebral ischemia-reperfusion injury in rats","volume":"32","author":"Deng Hong","year":"2017","journal-title":"West China J. Pharm. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1213\/ANE.0b013e31827d204d","article-title":"The pyrrole etomidate analog carboetomidate potently inhibits human 5-HT3A receptor function: comparisons with etomidate and potential implications for emetogenesis","volume":"116","author":"Desai","year":"2013","journal-title":"Anesth. Analg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7071","DOI":"10.1038\/s41598-024-57581-2","article-title":"Pharmacokinetic and pharmacodynamic evaluation study of etomidate: a randomized, open-label, 2-period crossover study in healthy Chinese subjects","volume":"14","author":"Ding","year":"2024","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/ALN.0b013e3181ae8460","article-title":"Is anesthesiology going soft? trends in fragile pharmacology","volume":"111","author":"Egan","year":"2009","journal-title":"Anesthesiology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1213\/ANE.0000000000004654","article-title":"The influence of hemorrhagic shock on the disposition and effects of intravenous anesthetics: a narrative review","volume":"130","author":"Egan","year":"2020","journal-title":"Anesth. Analg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/ALN.0b013e3181ff72b5","article-title":"Clinical and molecular pharmacology of etomidate","volume":"114","author":"Forman","year":"2011","journal-title":"Anesthesiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/00000542-198412000-00004","article-title":"Effects of etomidate on hormonal responses to surgical stress","volume":"61","author":"Fragen","year":"1984","journal-title":"Anesthesiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1365-2265.1984.tb00112.x","article-title":"The inhibition by etomidate of the 11 beta-hydroxylation of cortisol","volume":"20","author":"Fry","year":"1984","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/ALN.0b013e31826d3de2","article-title":"Electroencephalographic and hypnotic recoveries after brief and prolonged infusions of etomidate and optimized soft etomidate analogs","volume":"117","author":"Ge","year":"2012","journal-title":"Anesthesiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/cc12494","article-title":"Adrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate","volume":"17","author":"Ge","year":"2013","journal-title":"Crit. Care"},{"key":"B23","first-page":"225","article-title":"Guidance on clinical application of etomidate (2023 edition)","volume":"45","year":"2024","journal-title":"Int. J. Anesthesiol. Resusc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1378\/chest.14-1012","article-title":"Single-dose etomidate does not increase mortality in patients with sepsis: a systematic review and meta-analysis of randomized controlled trials and observational studies","volume":"147","author":"Gu","year":"2015","journal-title":"Chest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/ALN.0b013e31826d3bef","article-title":"Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action","volume":"117","author":"Husain","year":"2012","journal-title":"Anesthesiology"},{"key":"B26","first-page":"92","article-title":"Etomidate, a potent non-barbiturate hypnotic. Intravenous etomidate in mice, rats, guinea-pigs, rabbits and dogs","volume":"214","author":"Janssen","year":"1975","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e3693","DOI":"10.7717\/peerj.3693","article-title":"Minimum infusion rate and adrenocortical function after continuous infusion of the novel etomidate analog ET-26-HCl in rats","volume":"5","author":"Jiang","year":"2017","journal-title":"PeerJ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.csbj.2021.01.002","article-title":"Discovery of the EL-0052 as a potential anesthetic drug","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s44254-024-00062-6","article-title":"Advance of a new etomidate analogue \u2014 methoxyethyl etomidate hydrochloride (ET-26) for anesthesia induction in surgical patients","volume":"2","author":"Jiang","year":"2024","journal-title":"Anesthesiol. Perioper. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3390\/jcm9082424","article-title":"Neurologic safety of etomidate-based sedation during upper endoscopy in patients with liver cirrhosis compared with propofol: a double-blind, randomized controlled trial","volume":"9","author":"Jung","year":"2020","journal-title":"J. Clin. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/bja\/48.3.213","article-title":"A dose-response relationship for etomidate, with some observations on cumulation","volume":"48","author":"Kay","year":"1976","journal-title":"Br. J. Anaesth."},{"key":"B32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40272-017-0241-5","article-title":"Pharmacologic considerations for pediatric sedation and anesthesia outside the operating room: a review for anesthesia and non-anesthesia providers","volume":"19","author":"Khurmi","year":"2017","journal-title":"Pediatr. Drugs"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1213\/ANE.0b013e318299a516","article-title":"Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery","volume":"117","author":"Komatsu","year":"2013","journal-title":"Anesth. Analg."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/s0140-6736(83)92712-5","article-title":"Influence of sedation on mortality in critically ill multiple trauma patients","volume":"1","author":"Ledingham","year":"1983","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.13375\/j.cnki.wcjps.2023.02.003","article-title":"Synthesis, metabolism in vitro and pharmacodynamic evaluation of etomidate soft analog ET-25-2","volume":"38","author":"Li Xin","year":"2023","journal-title":"West China J. Pharm. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0190994","DOI":"10.1371\/journal.pone.0190994","article-title":"The etomidate analog ET-26 HCl retains superior myocardial performance: comparisons with etomidate in vivo and in vitro","volume":"13","author":"Liu","year":"2018","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1208\/s12248-024-01004-7","article-title":"Pharmacokinetic-pharmacodynamic modelling of NH600001 in healthy subjects and patients undergoing gastroscopy","volume":"27","author":"Liu","year":"2024","journal-title":"AAPS J."},{"key":"B38","article-title":"A phase 1 dose optimization study of ABP-700 with opiates and\/or midazolam targeting induction of general anesthesia","volume":"122","author":"Meier","year":"2016","journal-title":"Anesth. Analgesia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0013-4694(80)90019-x","article-title":"Neurophysiological effects of etomidate, a new short-acting hypnotic","volume":"50","author":"Meinck","year":"1980","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3760\/cma.j.issn.1673-4378.2013.02.011","article-title":"Research progress of etomidate","volume":"34","author":"Pan","year":"2013","journal-title":"Int. J. Anesthesiol. Resusc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1213\/ANE.0b013e3182320559","article-title":"In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate","volume":"115","author":"Pejo","year":"","journal-title":"Anesth. Analg."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/ALN.0b013e3182515403","article-title":"Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats","volume":"116","author":"Pejo","year":"","journal-title":"Anesthesiology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/CCM.0b013e31822d7924","article-title":"Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia","volume":"40","author":"Pejo","year":"","journal-title":"Crit. Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1213\/ANE.0000000000001146","article-title":"Distinct hypnotic recoveries after infusions of methoxycarbonyl etomidate and cyclopropyl methoxycarbonyl metomidate: the role of the metabolite","volume":"122","author":"Pejo","year":"2016","journal-title":"Anesth. Analg."},{"key":"B45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40263-024-01128-6","article-title":"The role of GABA receptors in anesthesia and sedation: an updated review","volume":"39","author":"Philip","year":"2025","journal-title":"CNS Drugs"},{"key":"B46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10822-007-9128-9","article-title":"Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics","volume":"21","author":"Roumen","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"B47","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/ALN.0000000000000721","article-title":"Cyclopropyl-methoxycarbonyl metomidate: studies in a lipopolysaccharide inflammatory model of sepsis","volume":"123","author":"Santer","year":"2015","journal-title":"Anesthesiology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1213\/ANE.0b013e31828b3637","article-title":"Carboetomidate: an analog of etomidate that interacts weakly with 11\u03b2-hydroxylase","volume":"116","author":"Shanmugasundararaj","year":"2013","journal-title":"Anesth. Analg."},{"key":"B49","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1038\/s41598-023-33679-x","article-title":"Clinical outcomes after a single induction dose of etomidate versus ketamine for emergency department sepsis intubation: a randomized controlled trial","volume":"13","author":"Srivilaithon","year":"2023","journal-title":"Sci. Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/ALN.0000000000001662","article-title":"A phase 1, single-center, double-blind, placebo-controlled study in healthy subjects to assess the safety, tolerability, clinical effects, and pharmacokinetics-pharmacodynamics of intravenous cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a single ascending bolus dose","volume":"127","author":"Struys","year":"2017","journal-title":"Anesthesiology"},{"key":"B51","first-page":"1411","article-title":"Research progress on common adverse reactions of etomidate and new prevention strategies","volume":"16","author":"Taiyun Wang","year":"2021","journal-title":"China Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.bja.2018.01.038","article-title":"Safety and clinical effect of i.v. infusion of cyclopropyl-methoxycarbonyl etomidate (ABP-700), a soft analogue of etomidate, in healthy subjects","volume":"120","author":"Valk","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"B53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/ALN.0000000000002758","article-title":"Toxicologic and inhibitory receptor actions of the etomidate analog ABP-700 and its metabolite CPM-Acid","volume":"131","author":"Valk","year":"2019","journal-title":"Anesthesiology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/ALN.0000000000003590","article-title":"Modeling the effect of excitation on depth of anesthesia monitoring in \u03b3-Aminobutyric acid type A receptor agonist ABP-700","volume":"134","author":"Valk","year":"2021","journal-title":"Anesthesiology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/ACO.0b013e328362a84c","article-title":"Pros and cons of etomidate \u2013 more discussion than evidence?","volume":"26","author":"van den Heuvel","year":"2013","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00134-007-0970-y","article-title":"Duration of adrenal inhibition following a single dose of etomidate in critically ill patients","volume":"34","author":"Vinclair","year":"2008","journal-title":"Intensive Care Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/00000542-198412000-00003","article-title":"Etomidate inhibits adrenocortical function in surgical patients","volume":"61","author":"Wagner","year":"1984","journal-title":"Anesthesiology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJM198405313102202","article-title":"Inhibition of adrenal steroidogenesis by the anesthetic etomidate","volume":"310","author":"Wagner","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1213\/ANE.0000000000002063","article-title":"An etomidate analogue with less adrenocortical suppression, stable hemodynamics, and improved behavioral recovery in rats","volume":"125","author":"Wang","year":"","journal-title":"Anesth. Analg."},{"key":"B60","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejps.2017.09.005","article-title":"Pharmacologic studies on ET-26 hydrochloride in a rat model of lipopolysaccharide-induced sepsis","volume":"109","author":"Wang","year":"","journal-title":"Eur. J. Pharm. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e0183439","DOI":"10.1371\/journal.pone.0183439","article-title":"ET-26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats","volume":"12","author":"Wang","year":"","journal-title":"PLoS One"},{"key":"B62","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1124\/jpet.121.000691","article-title":"A novel etomidate analog EL-0052 retains potent hypnotic effect and stable hemodynamics without suppressing adrenocortical function","volume":"379","author":"Xu","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejps.2016.12.041","article-title":"Metabolite-inactive etomidate analogues alleviating suppression on adrenal function in Beagle dogs","volume":"99","author":"Yang","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0310057X8000800417","article-title":"Etomidate: a foreshortened clinical trial","volume":"8","author":"Yelavich","year":"1980","journal-title":"Anaesth. Intensive Care"},{"key":"B65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bja.2024.09.009","article-title":"Phase 1 single-centre placebo- and etomidate-controlled study in healthy volunteers to assess safety, tolerability, clinical effects, and pharmacokinetics of intravenous methoxyethyl etomidate hydrochloride (ET-26)","volume":"134","author":"Yin","year":"2025","journal-title":"Br. J. Anaesth."},{"key":"B66","doi-asserted-by":"publisher","first-page":"191666","DOI":"10.1098\/rsos.191666","article-title":"Metabolite identification, tissue distribution, excretion and preclinical pharmacokinetic studies of ET-26-HCl, a new analogue of etomidate","volume":"7","author":"Yu","year":"2020","journal-title":"R. Soc. Open Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1197\/j.aem.2005.11.076","article-title":"Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study","volume":"13","author":"Zed","year":"2006","journal-title":"Acad. Emerg. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2174\/1389200221666191223105504","article-title":"Preclinical pharmacokinetics study of a novel intravenous anesthetic ET-26 hydrochloride","volume":"20","author":"Zhang","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/jat.3970","article-title":"Non-clinical single- and repeated-dose toxicity studies of ET-26 hydrochloride in rats","volume":"40","author":"Zhang","year":"","journal-title":"J. Appl. Toxicol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/jat.3936","article-title":"Preclinical safety evaluation of ET-26 hydrochloride, a novel intravenous anesthetic agent, in beagle dogs","volume":"40","author":"Zhang","year":"","journal-title":"J. Appl. Toxicol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"679381","DOI":"10.3389\/fphar.2021.679381","article-title":"Safety pharmacology study of ET-26 hydrochloride, a potential drug for intravenous general anesthesia, in rats and beagle dogs","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1021\/acs.molpharmaceut.4c00325","article-title":"The application and pharmaceutical development of etomidate: challenges and strategies","volume":"21","author":"Zhang","year":"2024","journal-title":"Mol. Pharm."},{"key":"B73","first-page":"733","article-title":"Application status of etomidate and research progress of its derivatives","volume":"23","author":"Zhang Jingwen","year":"2019","journal-title":"Anhui Med. Pharm. J."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1614865\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T08:07:24Z","timestamp":1760429244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1614865\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":73,"alternative-id":["10.3389\/fphar.2025.1614865"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1614865","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"article-number":"1614865"}}